CUHK’s faculty of medicine said it is the first in the world to make use of a self-built robotic system to help doctors remove a tumour in the bladder in one piece, which can also lower the chance of a bladder cancer recurrence.

A CUHK-led multinational study proved that a new drug (D3S-001) developed by a mainland Chinese biotechnology company is effective in combating three types of cancer that currently have limited treatment options.

In this episode (begins from 39:09), main architect of CUHK Art Museum’s new Lo Kwee Seong Pavilion explains the architectural gist, while the museum’s Director Professor Josh Yiu introduces its inaugural exhibition.

In an exclusive interview, Professor Dennis Lo, Vice-Chancellor and President of CUHK, shares that increasing geopolitics uncertainties have benefited the University in attracting talent, and CUHK had hired over 150 academics from more than 10 places since 2023.

A research team at CUHK discovered a new underlying mechanism and possible therapeutic target for Huntington’s disease, a rare, incurable illness that can cause twitching movements and cognitive decline.

An international research team led by CUHK has achieved a breakthrough in the field of medical microrobots by developing the world’s first antibiofilm liquid-bodied magnetic-controlled robot, a new solution to combat biofilm infections.

CUHK has established Asia’s first bladder cancer organoid biobank, advancing precision medicine. This initiative offers new hope for personalised bladder cancer treatments, enhancing outcomes in Hong Kong and Asia.

A study by CUHK ophthalmology experts shows that the prevalence and severity of refractive and corneal astigmatisms increased among children after the COVID-19 pandemic.

CUHK successfully identifies molecular features in plasma EBV DNA associated with nasopharyngeal cancer, achieving a detection accuracy of up to 97% by recognising EBV DNA associated to cancer.

CUHK reported encouraging results from a clinical trial where five cancer patients tested a CAR-T therapy, showing significant improvement in their condition.

Researchers from CUHK and Harvard University developed a technique using silica nanoparticles to increase drug solubility by up to three orders of magnitude, potentially revolutionising drug formulation.

CUHK found that children born during the pandemic are more likely to develop eczema due to over-sanitisation, which disrupts the development of healthy gut bacteria.